You are here

Situation Report

Not to be sniffed at: Agony of post-COVID-19 loss of smell

Researchers still investigating loss of smell problems among some of Covid victims

 ... A year into the coronavirus pandemic, doctors and researchers are still striving to better understand and treat the accompanying epidemic of COVID-19-related anosmia — loss of smell — draining much of the joy of life from an increasing number of sensorially frustrated longer-term sufferers like Forgione.

Even specialist doctors say there is much about the condition they still don’t know and they are learning as they go along in their diagnoses and treatments. Impairment and alteration of smell have become so common with COVID-19 that some researchers suggest that simple odor tests could be used to track coronavirus infections in countries with few laboratories.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Institutional investors urge a more ‘fair and equitable’ international Covid-19 response

Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued a joint call for a “fair and equitable” global response to the Covid-19 pandemic, and they intend to huddle with health care companies to make progress on that goal.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OVERVIEW: U.S. and International

 
 

SACRAMENTO, Calif. -- California lawmakers have cleared the way for 5.7 million people to get at least $600 in one-time payments, part of a state-sized coronavirus relief package aimed at helping lower-income people weather what they hope is the last legs of the pandemic.

The state Legislature passed the bill by a wide margin on Monday...

BUDAPEST — Officials in Hungary are urging people to trust in the vaccines already approved by the country ahead of a planned rollout Wednesday of a COVID-19 vaccine developed in China.

Problem, Solution, SitRep, or ?: 

British data study says COVID-19 vaccines sharply cut hospitalizations

 

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

 

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Problem, Solution, SitRep, or ?: 

U.S. crosses 500,000th COVID-19 death

NEW YORK (Reuters) - The United States on Monday crossed the staggering milestone of 500,000 COVID-19 deaths just over a year since the coronavirus pandemic claimed its first known victim in Santa Clara County, California.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Situation Report
howdy folks
Page loaded in 1.571 seconds.